In this videoShare Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailWe are focused on consolidating our acquired businesses for the coming fiscal year: Biocon BiologicsShreehas Tambe of Biocon Biologics discusses the company's earnings results for the third quarter of fiscal year 2024 following its acquisition of pharmaceutical company Viatris.
Persons:
Biocon, Biocon Biologics